Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...
Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback